Lilly(Eli) & Co

Market cap: $713,354,965,628

Exchange: NYS

Sector: Health Technology

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. Its products include Forteo, Adrica, BAQSIMI, Basaglar and Glucagn. The company was founded by Eli Lilly on May 1876 and is headquartered in Indianapolis, IN.

Key Statistics

Company Name

Lilly(Eli) & Co

Average Volume (10 days)

2,321,820

Average Volume (30 days)

2,399,248

Moving Average (50 days)

$766.02

Moving Average (200 days)

$655.8

Ex-Divided Date

Feb 14, 2024

Dividend Yield

0.0062

P/E Ratio

136.1261

Market Cap

713,354,965,628

Shares Outstanding

950,164,452

52-Week High Split Adjust Only

800.78

52-Week Low Split Adjust Only

366.69

Employee Count

39,000

Beta

0

Next Earnings Date

2024-04-30

TTM Dividend Rate Per Share

4.6775

Price Changes

Past 5 days

-0.01%

Past 30 days

0%

Past 3 months

0.2%

Past 6 months

0.24%

Past year

1.03%

Past 2 years

1.54%

Past 5 years

5.96%

Max % Change

22.43%

PEER GROUP COMPARATIVE PERFORMANCE

NameTickerPrice/Sales (ttm)Price/Book (ttm)Forward P/EPEG RatioEV/Revenue
Lilly(Eli) & CoLLY7.5227.7725.27.528.03
Peer AvgN/A4.187.154.54.184.82
Johnson & JohnsonJNJ5.296.77n/a5.295.40
Merck & Co IncMRK4.007.1311.74.004.51
Abbvie IncABBV3.9814.58n/a3.985.49
Astrazeneca plc - ADRAZN5.4010.33n/a5.405.85
Novartis AG - ADRNVS4.374.32n/a4.375.05
Pfizer Inc.PFE4.883.1610.24.885.46
AMGEN Inc.AMGN5.4314.6514.65.436.31
Sanofi - ADRSNY2.931.74n/a2.933.17
Bristol-Myers Squibb Co.BMY3.433.908.83.434.21
Glaxosmithkline plc - ADRGSK2.104.91n/a2.102.71